In vitro pancreatic differentiation of pluripotent mammalian cells
First Claim
1. A method for producing a population of pancreatic progenitor cells which comprises:
- i) providing a population of pluripotent cells;
ii) culturing the population in a definitive endoderm (DE) induction medium to produce a population of definitive endoderm cells, wherein the definitive endoderm (DE) induction medium comprises a TGFβ
ligand, fibroblast growth factor (FGF), bone morphogenetic protein (BMP), a PI3K inhibitor and a GSK3β
inhibitor;
iii) culturing the population of definitive endoderm cells in a first pancreatic induction medium comprising an activin antagonist;
FGF;
retinoic acid; and
a BMP inhibitor to produce a population of dorsal foregut cells;
iv) culturing the dorsal foregut cells in a second pancreatic induction medium comprising FGF, retinoic acid, a BMP inhibitor, and a hedgehog signalling inhibitor;
v) culturing the cells produced in step (iv) in a third pancreatic induction medium comprising FGF;
thereby producing a population of pancreatic progenitor cells.
1 Assignment
0 Petitions
Accused Products
Abstract
This invention relates to the in vitro differentiation of pluripotent cells into pancreatic progenitors by i) culturing pluripotent cells in a definitive endoderm (DE) medium comprising a TGFp ligand, fibroblast growth factor (FGF), bone morphogenetic protein (BMP), a PI3K inhibitor and optionally a GSK3 β inhibitor to produce a population of definitive endoderm cells, ii) culturing the definitive endoderm cells in a first pancreatic medium comprising an activin antagonist; FGF; retinoic acid; and a BMP inhibitor to produce a population of dorsal foregut cells; iii) culturing the dorsal foregut cells in a second pancreatic medium comprising FGF, retinoic acid, a BMP inhibitor, and a hedgehog signalling inhibitor, and; iv) culturing the endoderm cells in a third pancreatic medium comprising FGF. The progenitor cells thus produced may be further differentiated into pancreatic endocrine cells. These methods may be useful, for example, in producing pancreatic cells for therapy or disease modelling.
-
Citations
39 Claims
-
1. A method for producing a population of pancreatic progenitor cells which comprises:
-
i) providing a population of pluripotent cells; ii) culturing the population in a definitive endoderm (DE) induction medium to produce a population of definitive endoderm cells, wherein the definitive endoderm (DE) induction medium comprises a TGFβ
ligand, fibroblast growth factor (FGF), bone morphogenetic protein (BMP), a PI3K inhibitor and a GSK3β
inhibitor;iii) culturing the population of definitive endoderm cells in a first pancreatic induction medium comprising an activin antagonist;
FGF;
retinoic acid; and
a BMP inhibitor to produce a population of dorsal foregut cells;iv) culturing the dorsal foregut cells in a second pancreatic induction medium comprising FGF, retinoic acid, a BMP inhibitor, and a hedgehog signalling inhibitor; v) culturing the cells produced in step (iv) in a third pancreatic induction medium comprising FGF; thereby producing a population of pancreatic progenitor cells. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39)
-
Specification